Pharma Journalist -

Valneva SE announced that the U.S. Food and Drug Administration (FDA) has lifted its previously recommended pause on the use of the company’s Chikungunya vaccine, IXCHIQ, in individuals…
Read More...

Genmab A/S announced promising Phase 3 results from its EPCORE FL-1 clinical trial, which evaluated epcoritamab—a subcutaneous bispecific antibody—combined with rituximab and…
Read More...

Cingulate Inc., a biopharmaceutical company specializing in next-generation pharmaceutical products through its proprietary Precision Timed Release (PTR) technology, announced it has…
Read More...

Fresenius Kabi is expanding its biopharmaceutical portfolio through a new global licensing agreement with Polpharma Biologics S.A., securing exclusive rights to commercialize the…
Read More...

In a significant development for pediatric migraine care, Teva Pharmaceuticals announced that the U.S. Food and Drug Administration (FDA) has approved an expanded indication for AJOVY…
Read More...

Jazz Pharmaceuticals plc announced that the U.S. Food and Drug Administration (FDA) has granted accelerated approval for Modeyso (dordaviprone) for the treatment of adult and pediatric…
Read More...

The 3rd Spatial Biology for Drug Development Summit Boston, MA | October 22-23, 2025 *Free to Attend for Biopharma Experts Spatial biology is at a turning point. Advances in…
Read More...

Astria Therapeutics, Inc. has entered into an exclusive licensing agreement with Kaken Pharmaceutical Co., Ltd., granting Kaken the rights to develop and commercialize navenibart in…
Read More...

Axplora, a global leader in API small molecule manufacturing, has announced a €6.5 million investment to expand production capacity at its Vizag site in India. This move aims to boost…
Read More...

SERB Pharmaceuticals, a global specialty pharma company focused on rare diseases and medical emergencies, announced it has entered a definitive agreement to acquire Y-mAbs Therapeutics,…
Read More...